查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1835109

事後緊急避孕藥市場（按產品類型、配方類型和年齡分類）—2025-2032 年全球預測

Emergency Contraceptive Pills Market by Product Type, Prescription Type, Age Group - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

事後緊急避孕藥市場預計到 2032 年將成長至 18.2 億美元，複合年成長率為 6.64%。

主要市場統計數據
基準年2024年 10.8億美元
預計2025年 11.6億美元
預測年份：2032年 18.2億美元
複合年成長率（%） 6.64%

簡要介紹影響事後緊急避孕藥取得和交付的當代臨床、監管和消費者力量。

影響事後緊急避孕藥的新動態來自臨床、監管和消費者主導。藥理學的進步和不斷發展的臨床指南正在改變這些產品在臨床和零售通路的定位。同時，監管機構和公共衛生部門持續調整取得途徑，包括非商店藥和遠端醫療輔助配藥，擴大了提供時效性照護的機制範圍。

隨著數位健康平台、消費者教育宣傳活動以及日益成長的生殖自主意識影響需求模式，消費行為也在改變。這種轉變也伴隨著供給面的轉型。製造商正在調整配方、包裝和分銷管道，以滿足快速獲取的期望，同時克服採購和製造方面的限制。在接下來的周期中，相關人員必須在實證臨床訊息和切實可行的獲取解決方案之間取得平衡，以確保安全及時地使用，並減輕延遲治療的恥辱感。

監管變化、遠端醫療的擴展和數位商務將如何改變事後緊急避孕藥的取得、分銷和競爭定位

由於監管調整、醫療途徑數位化以及消費者期望的變化，事後緊急避孕藥格局正在轉變。監管機構正在逐步修訂非處方藥框架和標籤，以擴大安全取得管道。同時，許多醫療系統正在整合遠距遠端醫療途徑，以縮短治療時間並在必要時維持臨床監測。同時，網路藥局和零售連鎖店正在打造無縫的購買和履約體驗，在加速消費者取得藥品的同時，又不影響諮詢或安全保障。

在供應方面，配方創新和包裝重新設計正著眼於以用戶為中心的特性，以減少劑量錯誤並提高謹慎的可及性。這一轉變促使老牌和新進者製造商重新定位競爭，優先考慮快速上架和全通路分銷。因此，監管敏捷性、與數位管道的協作以及臨床營運、商業化和供應鏈團隊之間的跨職能協作已成為在保障患者安全的同時抓住新商機的戰略要務。

評估 2025 年關稅轉變如何增強事後緊急避孕藥產品管道的供應鏈重組、採購多樣化和成本管理。

有關關稅實施的政策決定將對醫藥供應鏈、籌資策略和產品定價動態產生實際的下游影響。 2025年的關稅給進口活性藥物原料藥和最終產品帶來了額外的成本壓力，迫使買家和製造商重新評估籌資策略。為此，一些製造商加快了替代供應商的資格審查或轉移了生產基地，以盡量減少進口關稅的影響，而另一些製造商則吸收了增加的成本，以保持在敏感治療類別的零售競爭力。

這些調整導致供應鏈透明度和合約彈性日益受到重視。採購團隊越來越重視多源供應商網路以及內建緊急條款的長期供應商關係。同時，監控監管和貿易政策已成為商業規劃團隊的核心能力，因為關稅波動會影響庫存政策和跨境分銷協議。總體而言，2025年關稅的累積影響引發了垂直整合、近岸外包討論的增加，以及對製造和分銷節點成本管理的更多關注。

深入洞察揭示產品類型、配方和年齡層如何影響緊急避孕藥的取得、通訊和管道策略

深刻的市場細分揭示了差異化的需求促進因素和獲取途徑，需要客製化的策略回應。按產品類型分類，levonorgestrel、米非司酮和醋酸烏利司他之間的市場動態在臨床適應症、給藥持續時間和監管狀態方面有所不同，這會影響標籤檢視、消費者指導和分銷選擇。按處方箋類型分類，OTC 和處方箋之間的差異決定了通路策略、患者諮詢要求和付款人互動。

按年齡細分也有助於精準推廣和包裝：在各個年齡層中，15-19歲、20-24歲、25-29歲和30歲以上的人群擁有不同的健康素養、購買偏好和隱私期望。年輕族群傾向於選擇數位優先的資訊管道和謹慎的履約方式，而老年人則可能更傾向於面對面的臨床諮詢和豐富的產品資訊。這些細分視角為產品經理和病人參與團隊提供了一個實用的框架，使他們能夠根據臨床限制和消費行為，設計差異化的行銷方案、教育材料和經銷夥伴關係。

比較區​​域觀點突顯了法律規範、文化規範和製造足跡如何推動世界各地不同的獲取和分銷策略

區域動態正在顯著不同地塑造監管方法、供應鏈架構和消費者獲取模式。在美洲，政策討論和倡導正在推動透過非處方藥和遠端醫療服務相結合的方式擴大獲取途徑，從而形成了由成熟分銷網路支持的強勁零售和電商管道。相較之下，歐洲、中東和非洲的監管格局複雜多樣，取得途徑因國家政策、文化規範和報銷制度而異，需要製定量身定做的監管策略和相關人員參與計畫。

亞太地區兼具高產量製造能力和快速發展的數位醫療應用，使其成為重要的製造中心和充滿活力的消費分銷創新市場。這些地區差異需要差異化的商業性策略，而監管投入、本地夥伴關係以及文化契合的溝通對於應對政策差異並最佳化跨司法管轄區的產品定位至關重要。

競爭對手的行動和策略重點：製造商、學名藥和數位參與企業如何塑造產品取得和分銷生態系統

活躍於事後緊急避孕藥的主要企業正在推行反映產品組合深度、通路覆蓋和製造能力的策略。現有的製藥商正在利用其規模、監管經驗以及與批發商的傳統關係來維持廣泛的分銷管道，而學名藥製造商則專注於成本效益和在監管途徑允許的情況下快速推出產品。新興企業，包括專業生物技術和數位健康平台，正專注於差異化服務模式，將遠端醫療與整合式履約和消費者教育相結合。

各類公司都採取了不同的策略舉措，包括投資配方改進、與連鎖藥局和線上平台合作，以及選擇性地擴大區域產能以降低貿易相關風險。重視臨床、監管和商業部門之間跨職能協調的公司，往往會加快產品上市速度，從而實現標籤更新和通路轉型。競爭優勢日益依賴在合規性、快速取得和以消費者為中心的設計之間取得平衡的能力，同時透過營運效率和供應鏈韌性來保障淨利率。

建議領導者採取行動，以增強供應彈性、擴大數位訪問，並使監管策略與以消費者為中心的商品銷售保持一致。

產業領導者應採取切實可行的措施，平衡醫療服務的可近性、安全性和商業性永續性。首先，應實現供應網路多元化，並投資於來源資格認證，以降低單一來源風險，而貿易政策波動會加劇這種風險。其次，應將遠端保健夥伴關係和數位商務能力整合到全通路策略中，以確保及時取得醫療服務，並涵蓋那些重視隱私和便利性的群體。

第三，將監管工作與商業計劃相結合，加快標籤澄清和臨床適用的非處方藥（OTC）轉換，同時確保產品標籤檢視和包裝符合實際使用要求。第四，投資進行針對不同人群和臨床受眾的有針對性的教育宣傳活動，以減少濫用並縮短治療時間。最後，實施先進的庫存和需求感知，以便在政策主導的供應中斷期間保持服務水平，並將情境規劃納入策略評估，以快速應對不斷變化的貿易和監管環境。

透明的調查方法概述：描述用於得出見解和策略意義的證據來源、相關人員諮詢和情境主導分析

該分析整合了監管備案文件、臨床指南更新、供應鏈趨勢報告和公開發布的政策公告，以形成切實可行的洞察。主要資訊包括監管決策和指導文件、貿易政策通知以及對供應鏈和商業行業領導者的匿名行業訪談，以指導分銷和籌資策略。次要資訊包括同儕審查的療效指標和安全性臨床文獻，以及總結的數位健康應用指標，以反映患者獲取管道的變化。

此分析方法結合了定性綜合分析和情境影響評估，以評估政策轉變、供應鏈中斷和管道演變的影響。透過比較獨立資訊來源與執業者的觀點進行交叉驗證，以確保一致性並發現需要密切監控的差距。倫理考量和病人安全始終貫穿整個調查方法的核心，並將臨床證據與權威指導文件進行交叉核對，以確保準確性和有效性。

結論性綜合強調，彈性、監管完整性和以病人為中心的策略是可靠的事後緊急避孕藥的支柱

事後緊急避孕藥的獨特之處在於其處於臨床緊迫性、政策敏感性和消費者偏好的交匯點，這為相關人員創造了機遇，也帶來了責任。隨著法律規範和數位管道的不斷發展，最成功的組織將是那些能夠快速將臨床證據轉化為安全獲取途徑，同時保持供應鏈穩健性和文化契合度溝通的組織。貿易政策、製造地和分銷網路之間的相互作用凸顯了採購靈活性的重要性，以及在不斷變化的環境下維持本地夥伴關係關係的價值。

展望未來，決策者應優先考慮監管、商業和臨床領域之間的互通性，以快速應對不斷變化的政策和公共衛生指導。注重彈性、以消費者為中心的設計和監管協調，將使相關人員能夠負責任地擴大緊急避孕措施的可近性，同時保障產品品質和病患治療效果。現在做出的策略選擇將決定誰能在快速變化和公眾擔憂日益加劇的環境下，可靠地提供及時安全的緊急避孕措施。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 遠端醫療平台在全國擴展處方箋和送貨上門服務
  • Z 世代社群媒體活動旨在提高大眾對事後緊急避孕藥的認知並促進其普及
  • 多布斯法案之後的政策變化影響了非處方事後緊急避孕藥的供應和價格
  • 將事後緊急避孕藥整合到數位健康應用程式中，並提供個人化的性交後指導
  • 對荷爾蒙殘留日益成長的環境擔憂推動環保包裝的創新
  • 亞馬遜藥房和線上零售商的電子商務滲透推動了按需藥丸購買

第6章 2025年美國關稅的累積影響

第7章 人工智慧的累積影響，2025年

第8章事後緊急避孕藥市場（依產品類型）

  • levonorgestrel
  • 米非司酮
  • 醋酸烏利司他

第9章事後緊急避孕藥市場（依處方類型）

  • 非處方藥
  • 處方箋

第 10 章事後緊急避孕藥市場（依年齡層）

  • 15至19歲
  • 20-24歲
  • 25-29歲
  • 30歲或以上

第11章事後緊急避孕藥市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第12章事後緊急避孕藥市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章事後緊急避孕藥市場（按國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Bayer AG
    • Teva Pharmaceutical Industries Ltd
    • Viatris Inc
    • Cipla Ltd
    • Dr. Reddy's Laboratories Ltd
    • Lupin Ltd
    • Sandoz International GmbH
    • Perrigo Company plc
    • Glenmark Pharmaceuticals Ltd
    • Apotex Inc
Product Code: MRR-43798151BF31

The Emergency Contraceptive Pills Market is projected to grow by USD 1.82 billion at a CAGR of 6.64% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 1.08 billion
Estimated Year [2025] USD 1.16 billion
Forecast Year [2032] USD 1.82 billion
CAGR (%) 6.64%

A succinct introduction to contemporary clinical, regulatory, and consumer forces reshaping access and delivery of emergency contraceptive pills

The emergent dynamics shaping emergency contraceptive pills are simultaneously clinical, regulatory, and consumer-driven. Advances in pharmacology and evolving clinical guidelines have altered how these products are positioned in clinical practice and retail channels. At the same time, regulatory agencies and public health authorities continue to adjust access pathways, including over-the-counter availability and telehealth-enabled prescribing, which has broadened the range of delivery mechanisms for time-sensitive care.

Consumer behavior is also shifting, as digital health platforms, consumer education campaigns, and greater awareness of reproductive autonomy influence demand patterns. This transition is accompanied by supply-side transformations: manufacturers are adapting formulations, packaging, and distribution to meet rapid-access expectations while navigating procurement and manufacturing constraints. In the coming cycles, stakeholders must balance evidence-based clinical messaging with pragmatic access solutions to ensure safe, timely use and to mitigate stigma that can delay care.

How regulatory shifts, telehealth expansion, and digital commerce are jointly transforming access, distribution, and competitive positioning for emergency contraceptive pills

The landscape for emergency contraceptive pills has experienced transformative shifts driven by regulatory recalibration, digitization of care pathways, and changes in consumer expectations. Regulatory authorities progressively reassess over-the-counter frameworks and labeling to expand safe access, while many health systems are integrating telemedicine pathways to shorten time-to-treatment and preserve clinical oversight where needed. Simultaneously, e-pharmacies and retail chains are creating seamless purchase and fulfillment experiences that accelerate consumer access without compromising counseling and safety safeguards.

On the supply side, formulation innovation and packaging redesigns focus on user-centric features that reduce administration errors and improve discreet access. These transformations have catalyzed competitive repositioning among established manufacturers and newer entrants that prioritize speed-to-shelf and omnichannel distribution. As a result, strategic imperatives now center on regulatory agility, digital channel partnerships, and cross-functional alignment between clinical affairs, commercialization, and supply chain teams to capture emerging opportunities while maintaining patient safety.

Assessing how tariff policy shifts in 2025 intensified supply chain reconfiguration, sourcing diversification, and cost management across emergency contraceptive product channels

Policy decisions regarding tariff implementation have tangible downstream effects on pharmaceutical supply chains, procurement strategies, and product pricing dynamics. Tariffs imposed in 2025 introduced additional cost pressures on imported active pharmaceutical ingredients and finished products, prompting buyers and manufacturers to reassess sourcing strategies. In response, some manufacturers accelerated qualification of alternative suppliers or shifted production footprints to minimize exposure to import duties, while others absorbed incremental costs to preserve retail competitiveness in sensitive therapeutic categories.

These adjustments have emphasized the value of supply chain transparency and contractual agility. Procurement teams increasingly prioritize multi-sourced supplier networks and longer-term supplier relationships that incorporate contingency clauses. Meanwhile, regulatory and trade policy monitoring has become a core competency for commercial planning teams, because tariff volatility can affect inventory policies and cross-border distribution agreements. Overall, the cumulative impact of tariffs in 2025 served as a catalyst for greater vertical integration, nearshoring conversations, and enhanced focus on cost management across manufacturing and distribution nodes.

Deep segmentation-based insights revealing how product type, prescription modality, and age cohorts influence access, messaging, and channel strategy for emergency contraception

Insightful segmentation reveals differentiated demand drivers and access pathways that require tailored strategic responses. Based on Product Type, market dynamics differ among Levonorgestrel, Mifepristone, and Ulipristal Acetate in terms of clinical indications, dosing windows, and regulatory status, which in turn influences labeling, consumer guidance, and distribution choices. Based on Prescription Type, the distinction between Over The Counter and Prescription availability shapes channel strategy, patient counseling requirements, and payer interactions, with OTC pathways demanding robust point-of-sale education and prescription routes requiring integrated clinician engagement.

Age-related segmentation also informs targeted outreach and packaging: Based on Age Group, the cohorts 15-19 Years, 20-24 Years, 25-29 Years, and 30 Years And Above display varying health literacy, purchasing preferences, and privacy expectations. Younger cohorts tend to favor digital-first information channels and discreet fulfillment options, whereas older cohorts may prioritize in-person clinical reassurance and broader product information. Together, these segmentation lenses provide an actionable framework for product managers and patient engagement teams to design differentiated marketing, educational materials, and distribution partnerships that align with clinical constraints and consumer behavior.

Comparative regional perspectives highlighting how regulatory frameworks, cultural norms, and manufacturing footprints drive distinct access and distribution strategies worldwide

Regional dynamics shape regulatory approaches, supply chain architecture, and consumer access models in markedly different ways. In the Americas, policy debates and advocacy have accelerated moves toward broader access with a mix of OTC availability and telehealth services, leading to robust retail and e-commerce channels supported by established distribution networks. In contrast, Europe, Middle East & Africa presents a heterogeneous regulatory mosaic where national policies, cultural norms, and reimbursement systems result in varying access pathways, requiring regionally tailored regulatory strategies and stakeholder engagement plans.

Asia-Pacific combines high-volume manufacturing capabilities with rapidly evolving digital health adoption; this region is simultaneously a major production base and a dynamic market for consumer-facing distribution innovations. These regional variances necessitate differentiated commercial playbooks, where regulatory intelligence, local partnerships, and culturally attuned communication are essential to navigate policy nuance and to optimize product positioning across jurisdictions.

Competitive company behaviors and strategic priorities showing how manufacturers, generics, and digital entrants are shaping product access and distribution ecosystems

Key companies active in emergency contraceptive pills are pursuing strategies that reflect portfolio depth, channel reach, and manufacturing capabilities. Established pharmaceutical manufacturers leverage scale, regulatory experience, and legacy relationships with wholesalers to maintain broad distribution, while generics producers focus on cost efficiency and rapid product launches where regulatory pathways permit. Emerging players, including specialized biotech and digital health platforms, concentrate on differentiated service models that combine telehealth prescribing with integrated fulfillment and consumer education.

Strategic moves observed across company types include investments in formulation enhancements, partnerships with pharmacy chains and online platforms, and selective regional capacity expansions to mitigate trade-related risks. Companies that prioritize cross-functional coordination between clinical affairs, regulatory teams, and commercial units tend to accelerate time-to-market for label updates and channel transitions. Competitive advantage increasingly depends on the ability to balance regulatory compliance, rapid access, and consumer-centric design while protecting margins through operational efficiency and supply chain resilience.

Actionable recommendations for leaders to strengthen supply resilience, expand digital access, and align regulatory strategy with consumer-centered commercialization

Industry leaders should adopt pragmatic measures that balance access, safety, and commercial sustainability. First, diversify supplier networks and invest in supplier qualification to reduce exposure to single-source risks exacerbated by trade policy fluctuations; this includes building regional manufacturing capacity or securing long-term supply agreements. Second, integrate telehealth partnerships and digital commerce capabilities into omnichannel strategies to ensure timely access and to reach cohorts that prioritize privacy and convenience.

Third, align regulatory affairs with commercial planning to expedite label clarifications and OTC transitions where clinically appropriate, while ensuring that product labeling and packaging address real-world use considerations. Fourth, invest in targeted education campaigns that resonate with distinct age cohorts and clinical audiences to reduce misuse and to improve time-to-treatment. Finally, implement advanced inventory and demand sensing practices to maintain service levels during policy-driven supply disruptions, and embed scenario planning into strategic reviews to respond swiftly to evolving trade and regulatory conditions.

A transparent methodological overview describing evidence sources, stakeholder consultations, and scenario-driven analysis used to derive insights and strategic implications

This analysis synthesizes regulatory filings, clinical guidance updates, supply chain trend reporting, and public domain policy announcements to triangulate actionable insights. Primary inputs included regulatory decisions and guidance documents, trade policy notices, and anonymized industry interviews with supply chain and commercial leaders, which together informed interpretation of distribution and sourcing strategies. Secondary inputs encompassed peer-reviewed clinical literature on efficacy windows and safety profiles, as well as aggregated digital health adoption indicators to contextualize changes in patient access channels.

Analytical methods combined qualitative synthesis with scenario-based impact assessment to evaluate implications of policy shifts, supply chain disruptions, and channel evolution. Cross-validation was performed by comparing independent sources and practitioner perspectives to ensure consistency and to surface areas of divergence that warrant closer monitoring. Ethical considerations and patient safety remained central throughout the methodology, and wherever applicable, clinical evidence was cross-checked against authoritative guidance documents to maintain accuracy and relevance.

A conclusive synthesis emphasizing resilience, regulatory alignment, and patient-centered strategies as the pillars for reliable emergency contraceptive access

Emergency contraceptive pills occupy a unique intersection of clinical urgency, policy sensitivity, and consumer preference, creating both opportunities and responsibilities for stakeholders. As regulatory frameworks and digital channels continue to evolve, the most successful organizations will be those that can rapidly translate clinical evidence into safe access pathways while maintaining supply chain robustness and culturally competent communication. The interplay between trade policy, manufacturing locus, and distribution networks underscores the importance of flexibility in sourcing and the value of local partnerships to sustain access under shifting conditions.

Moving forward, decision makers should prioritize interoperability across regulatory, commercial, and clinical domains to respond quickly to changes in policy or public health guidance. By focusing on resilience, consumer-focused design, and regulatory alignment, stakeholders can responsibly expand access while safeguarding product quality and patient outcomes. The strategic choices made now will determine who can reliably deliver timely, safe emergency contraception in a landscape defined by rapid change and heightened public attention.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Telehealth platforms expanding nationwide prescription and doorstep delivery of emergency contraceptive pills
  • 5.2. Introduction of ulipristal acetate generics reshaping competitive pricing dynamics in key markets
  • 5.3. Rising Gen Z social media advocacy driving awareness and accessibility of emergency contraception
  • 5.4. Post-Dobbs policy shifts influencing over-the-counter emergency contraceptive availability and pricing
  • 5.5. Integration of emergency contraceptives into digital health apps for personalized postcoital guidance
  • 5.6. Growing environmental concerns over hormone residues spurring eco-friendly packaging innovations
  • 5.7. E-commerce penetration by Amazon Pharmacy and online retailers boosting on-demand pill purchases

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Emergency Contraceptive Pills Market, by Product Type

  • 8.1. Levonorgestrel
  • 8.2. Mifepristone
  • 8.3. Ulipristal Acetate

9. Emergency Contraceptive Pills Market, by Prescription Type

  • 9.1. Over The Counter
  • 9.2. Prescription

10. Emergency Contraceptive Pills Market, by Age Group

  • 10.1. 15-19 Years
  • 10.2. 20-24 Years
  • 10.3. 25-29 Years
  • 10.4. 30 Years And Above

11. Emergency Contraceptive Pills Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Emergency Contraceptive Pills Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Emergency Contraceptive Pills Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Analysis
    • 14.3.1. Bayer AG
    • 14.3.2. Teva Pharmaceutical Industries Ltd
    • 14.3.3. Viatris Inc
    • 14.3.4. Cipla Ltd
    • 14.3.5. Dr. Reddy's Laboratories Ltd
    • 14.3.6. Lupin Ltd
    • 14.3.7. Sandoz International GmbH
    • 14.3.8. Perrigo Company plc
    • 14.3.9. Glenmark Pharmaceuticals Ltd
    • 14.3.10. Apotex Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. EMERGENCY CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. EMERGENCY CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. EMERGENCY CONTRACEPTIVE PILLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY LEVONORGESTREL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY MIFEPRISTONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY MIFEPRISTONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY MIFEPRISTONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY MIFEPRISTONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY MIFEPRISTONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY MIFEPRISTONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY ULIPRISTAL ACETATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY ULIPRISTAL ACETATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY ULIPRISTAL ACETATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY ULIPRISTAL ACETATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY ULIPRISTAL ACETATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY ULIPRISTAL ACETATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY OVER THE COUNTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY OVER THE COUNTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY OVER THE COUNTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY OVER THE COUNTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 15-19 YEARS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 15-19 YEARS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 15-19 YEARS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 15-19 YEARS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 15-19 YEARS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 15-19 YEARS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 20-24 YEARS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 20-24 YEARS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 20-24 YEARS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 20-24 YEARS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 20-24 YEARS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 20-24 YEARS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 25-29 YEARS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 25-29 YEARS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 25-29 YEARS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 25-29 YEARS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 25-29 YEARS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 25-29 YEARS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 30 YEARS AND ABOVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 30 YEARS AND ABOVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 30 YEARS AND ABOVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 30 YEARS AND ABOVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 30 YEARS AND ABOVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY 30 YEARS AND ABOVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 68. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 69. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 70. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 71. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 72. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 73. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. AMERICAS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 78. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 80. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. NORTH AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 86. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 88. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. LATIN AMERICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 95. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 102. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 103. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 104. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 105. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. EUROPE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 110. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 112. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. MIDDLE EAST EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 118. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 119. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 121. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. AFRICA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 137. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 139. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. ASEAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 145. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GCC EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. EUROPEAN UNION EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. BRICS EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 169. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. G7 EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. NATO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. UNITED STATES EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. CANADA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. MEXICO EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. BRAZIL EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. UNITED KINGDOM EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GERMANY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 222. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 223. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. FRANCE EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. RUSSIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. ITALY EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. SPAIN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. CHINA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. INDIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. JAPAN EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 266. AUSTRALIA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 267. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY PRESCRIPTION TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. SOUTH KOREA EMERGENCY CONTRACEPTIVE PILLS MARKET SIZE, BY AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. EMERGENCY CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 274. EMERGENCY CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2024